2022
DOI: 10.1016/j.jff.2022.105190
|View full text |Cite
|
Sign up to set email alerts
|

Vitexin alleviates breast tumor in mice via skewing TAMs toward an iNOS+ profile orchestrating effective CD8+ T cell activation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 41 publications
1
1
0
Order By: Relevance
“…64 Similarly, vitexin promotes apoptosis and cell cycle arrest. 65 In the present study, elevated expression of BRCA1, cMYC, EpCAM, iCAM, MMP9, iNOS, and NFkB in the mammary tissues of the tumor group was observed. In contrast, mRNA expression of tumour suppressor gene BRCA1 was downregulated in the case of niosome treated groups.…”
Section: Materials Advances Papersupporting
confidence: 58%
“…64 Similarly, vitexin promotes apoptosis and cell cycle arrest. 65 In the present study, elevated expression of BRCA1, cMYC, EpCAM, iCAM, MMP9, iNOS, and NFkB in the mammary tissues of the tumor group was observed. In contrast, mRNA expression of tumour suppressor gene BRCA1 was downregulated in the case of niosome treated groups.…”
Section: Materials Advances Papersupporting
confidence: 58%
“…[10,11] Vitexin, an apigenin flavone glucoside, is a key component of several edible and medicinal plants such as pearl millet and chasteberry. [12] It has been reported to exhibit antioxidant, anticonvulsant, antiinflammatory activity, and to regulate neuroinflammation [13,14] and have antidiabetic properties. [15] The lignans yangambin and epiyangambin are found in medicinal plants of several families including the Lauraceae [16] and Asteraceae.…”
Section: Introductionmentioning
confidence: 99%